OVID - Ovid Therapeutics Inc
IEX Last Trade
1.13
-0.070 -6.195%
Share volume: 190,991
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.07
-5.83%
Summary score
12%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.55%
Return on assets
-8.58%
Return on sales
-20031.73%
Return on invested capital
-55.68%
Total debt ratio
19.99%
Debt ratio change over timeo
-1.15%
Current Ratio
13.12%
Quick Ratio
13.8%
Cash Position Ratio
12.81%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.68%
Return on assets
-11.47%
Return on sales
-13637.73%
Return on invested capital
-50.97%
Total debt ratio
29.32%
Debt ratio change over timeo
-1.45%
Current Ratio
10.17%
Quick Ratio
10.17%
Cash Position Ratio
9.73%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-14.94%
Return on assets
-13.23%
Return on sales
-11768.24%
Return on invested capital
-39.59%
Total debt ratio
40.52%
Debt ratio change over time
-1.61%
Current Ratio
10.47%
Quick Ratio
10.47%
Cash Position Ratio
10.14%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.68%
Return on assets
-92.2%
Return on sales
27381.5%
Return on invested capital
-71.55%
Total debt ratio
-114.72%
Debt ratio change over time
-1.15%
Current Ratio
-10.55%
Quick Ratio
-11.3%
Cash Position Ratio
-10.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OVID | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.55% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.58% | 2.76% | 3.15% | 5.62% |
| Return on sales | -20031.73% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -55.68% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 19.99% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.15% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 10.17% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 10.17% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 9.73% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | OVID | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.68% | 13.77% | 13.25% | 3.8% |
| Return on assets | -11.47% | 2.43% | 1.89% | 3.09% |
| Return on sales | -13637.73% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -50.97% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 29.32% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.45% | 46.38% | -72.08% | 1.51% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 10.17% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 10.17% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 9.73% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 13% | 32% |